Detalhe da pesquisa
1.
Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
Int J Mol Sci
; 23(4)2022 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35216137
2.
ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity.
Mol Ther
; 27(11): 1878-1891, 2019 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31405808
3.
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model.
Cancer Immunol Immunother
; 68(3): 379-393, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30547218
4.
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.
Nat Med
; 29(3): 632-645, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928817
5.
Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10.
Hepatology
; 53(1): 23-31, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21154952
6.
A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice.
J Immunol
; 185(9): 5150-9, 2010 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20870946
7.
The role of dendritic cells in the immune niche of the peritoneum.
Int Rev Cell Mol Biol
; 371: 1-14, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35964997
8.
Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer.
Front Immunol
; 13: 985886, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36405725
9.
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination.
Front Immunol
; 13: 991311, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36300124
10.
Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy.
Oncoimmunology
; 11(1): 2070337, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35529677
11.
Neoantigens as potential vaccines in hepatocellular carcinoma.
J Immunother Cancer
; 10(2)2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35193931
12.
Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy.
Cancer Lett
; 499: 279-289, 2021 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33232788
13.
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
Emerg Microbes Infect
; 10(1): 1931-1946, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34538222
14.
A Proteomic Atlas of Lineage and Cancer-Polarized Expression Modules in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets.
J Pers Med
; 11(6)2021 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34208043
15.
Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses Against Hepatocellular Carcinoma.
Cancers (Basel)
; 12(11)2020 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33207844
16.
Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy.
Int J Cancer
; 125(11): 2614-23, 2009 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19530254
17.
Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein.
Mol Ther
; 16(1): 210-7, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17923840
18.
When Cancer Vaccines Go Viral.
Clin Cancer Res
; 25(16): 4871-4873, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31227502
19.
Engineered promiscuous T helper peptides for the induction of immune responses.
Mol Immunol
; 44(9): 2205-12, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17157914
20.
Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10.
Front Immunol
; 9: 1923, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30233565